Global Tobacco Control Treaty Has Reduced Smoking Rates

This article originally appeared here.
Share this content:
Global Tobacco Control Treaty Has Reduced Smoking Rates
Global Tobacco Control Treaty Has Reduced Smoking Rates

THURSDAY, March 23, 2017 (HealthDay News) -- After 180 countries agreed to a global tobacco control treaty in 2005, there was a 2.55 percent decrease in smoking worldwide during the next decade, according to a study published online March 21 in The Lancet Public Health.

All of the participating countries agreed to the World Health Organization Framework Convention on Tobacco Control. Signing countries committed to introducing policies such as high tobacco taxes and smoke-free public spaces. They also agreed to warning labels, advertising bans, and support for smoking cessation services. Geoffrey Fong, Ph.D., professor of psychology and health studies at the University of Waterloo in Canada, and colleagues reviewed data from 116 countries that signed the treaty and 10 that didn't.

The researchers found that, overall, smoking rates in the 126 countries fell from 24.23 percent in 2005 to 22.18 percent in 2015, an average decrease in prevalence of 2.55 percentage points. Smoking rates declined in 90 countries, remained the same in 12 countries, and actually went up in 24 nations. There were much larger reductions in smoking in countries that fully implemented more of the measures in the tobacco control treaty. Overall, each additional measure that was fully implemented was associated with a 1.57 percent reduction in smoking rates. The most frequently introduced measure was smoke-free public areas. Twenty-eight percent of the countries studied that were part of the treaty had implemented this measure. Only 13 percent of the countries implemented tobacco advertising bans.

"However, while the progress of WHO Framework Convention on Tobacco Control has been remarkable, there are still far too many countries where domestication of the treaty and its implementation has fallen short," Fong said in a journal news release. "One important cause of this is the tobacco industry's influence, particularly in low- and middle-income countries."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths